Bayer accused of promoting Yaz birth control for unapproved uses

Company faces off-label marketing allegations in lawsuits

For years, Bayer AG has faced lawsuits concerning the safety of its Yaz birth control medication. Now, the German drug company is accused of marketing its oral contraceptives for unapproved uses as well as keeping women in the dark about the drug’s health risks.

According to company emails that were disclosed as part of litigation in which plaintiffs claim that Yaz caused serious health problems, Bayer officials discussed how to promote Yaz as a treatment for all types of premenstrual syndrome (PMS) even though U.S. regulators had only approved the drug to treat the most severe form of PMS. Bayer officials sent salespeople an email saying that they should cite a Woman’s Day magazine article when touting Yaz as a safe PMS treatment.

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.